Company news

Valeo Pharma Inc. news in 2023

Valeo Pharma Inc.'s news releases, calls and decks from 2023, newest first.

View company

Valeo Pharma announces organizational changes and cost reduction initiatives

November 19, 2023

Valeo Pharma announces appointment of Mr. Richard Lajoie to board of directors

November 6, 2023

Valeo Pharma makes the list of The Globe and Mail's fifth-annual ranking of Canada's top growing companies

October 3, 2023

Valeo Pharma enters into $5 million credit facility agreement with accord financial inc.

September 26, 2023

Valeo Pharma reports record third quarter 2023 revenues

September 12, 2023

Valeo Pharma to host third quarter 2023 results conference call / webcast

September 6, 2023

Valeo Pharma closes $4.5 million financing

August 30, 2023

Valeo Pharma provides update on ophthalmology business unit

July 3, 2023

Valeo Pharma announces new board appointments

June 21, 2023

Valeo Pharma reports record second quarter revenues

June 12, 2023

Valeo Pharma to host second quarter 2023 results conference call / webcast

June 6, 2023

Valeo Pharma providing guidance of record revenues for the second quarter 2023

May 24, 2023

Valeo Pharma announces results of annual meeting of shareholders and committee appointments

April 27, 2023

Valeo Pharma to present at the 2023 bloom burton & co healthcare investor conference

April 18, 2023

Valeo Pharma reports record quarterly revenues for the first quarter 2023

March 14, 2023

Watch the Valeo Pharma Inc Presentation at the March 9, 2023 Life Sciences Investor Forum

March 10, 2023

Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing

March 9, 2023

Valeo Pharma to host first quarter 2023 results conference call / webcast

March 8, 2023

Valeo Pharma to Webcast Live at VirtualInvestorConferences.com March 9th

March 5, 2023

Valeo Pharma obtains public reimbursement for Onstryv® in Quebec

February 7, 2023

Valeo Pharma reports record quarterly and annual revenues for the fourth quarter and the fiscal year 2022

January 30, 2023

Valeo Pharma announces filing of a new drug submission-covid 19 with Health Canada for sabizabulin for the treatment of hospitalized COVID-19 patients

January 26, 2023

Decks in 2023